Avior Bio

Holly Springs, United States

Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.

$200K raised

Feb 2023

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Avior Bio raised?

Avior Bio has raised $200K in total funding. The most recent round was Debt Financing. The last funding was announced in February 2023.

Who are Avior Bio's investors?

Avior Bio's investors include National Science Foundation, North Carolina Biotechnology Center.

Where is Avior Bio headquartered?

Avior Bio is headquartered in Holly Springs, United States.

What does Avior Bio do?

Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.

What stage is Avior Bio at?

Avior Bio is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 17, 2023.

MLA

"Avior Bio — Funding & Investors." VCBacked, February 17, 2023, https://www.vcbacked.co/company/avior-bio. Accessed July 2, 2026.

APA

VCBacked. (2023). Avior Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/avior-bio

Wikipedia (cite web)

{{cite web |title=Avior Bio — Funding & Investors |url=https://www.vcbacked.co/company/avior-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 17, 2023.